Thomas J. Cable, a director at Omeros Corp (NASDAQ:OMER), recently disposed of 7,500 shares of the company's common stock. This transaction, which occurred on May 22, 2026, resulted in a total divestment value of $87,039.
The sale encompassed shares priced between $11.46 and $11.93 per share, establishing a weighted average selling price of $11.6052 per share for the 7,500 units. The timing of this transaction is noteworthy when considering Omeros's performance metrics. Over the preceding year, the company had achieved a substantial gain of 249%. However, more recently, the stock has experienced a decline of approximately 11% over the last week, settling at $11.07.
Market analysis provides context for the current valuation. According to InvestingPro analysis, OMER currently trades above its identified Fair Value, suggesting that potential upside movement may be limited in the near term. Deeper insights into OMER's valuation and patterns of insider activity are available through a comprehensive Pro Research Report.
The sale was structured under the framework of a Rule 10b5-1 trading plan. Mr. Cable initially adopted this plan on June 14, 2024. On that same date, he also engaged in an acquisition activity: acquiring 7,500 shares of common stock by exercising vested options. These options were valued at an exercise price of $10.84 per share, representing a total cost of $81,300. The original expiration date for these specific options was set for June 9, 2026.
Following the recent sale and acquisition activity detailed above, Mr. Cable's current direct holdings in Omeros Corp common stock amount to 35,067 shares.
The insider transactions are set against a backdrop of operational financial reporting. In other recent developments, Omeros Corporation disclosed its first-quarter earnings for 2026. These results showed notable misses compared to both analyst forecasts and internal expectations regarding key metrics.
Specifically, the company reported an Earnings Per Share (EPS) of -$0.24. This figure fell below the anticipated EPS estimate of -$0.12. Furthermore, Omeros announced total revenue of $9.89 million. This revenue amount was substantially lower than the projected expectation of $40.15 million.
These figures were revealed during an earnings call. During this call, management highlighted the ongoing commercialization efforts dedicated to its primary product, YARTEMLEA. The company reiterated that it maintains a solid cash position despite these financial outcomes. Despite the stated operational efforts and strong cash reserves, market reaction following the earnings miss was negative. Analysts' projections were not met, which likely contributed significantly to the subsequent adverse movement in market sentiment.
It is also noted that the earnings call did not provide any updates regarding potential mergers or acquisitions for Omeros Corporation. Furthermore, there have been no recent reports of analyst upgrades or downgrades issued specifically for Omeros Corporation.
Key Points and Market Implications
- The recent negative market reaction following the Q1 2026 earnings miss, particularly due to significant deviations from analyst projections.
- The observed trend of the stock declining approximately 11% in the past week, despite prior gains and stated commercialization efforts for YARTEMLEA.
- The current valuation standing above the determined Fair Value by external analysis (InvestingPro), which may constrain upward price movement.